Search research articles
Contact Us
Filters
Showing results (1-10 of 495) with videos related to
Page
of 50
Sort By:
Radiology
|
May 23, 2018
Why Is Cognitive Impairment Present in Multiple Sclerosis? Insights from Functional MRI
Robert Zivadinov
Journal of the Neurological Sciences
|
May 11, 2005
Steroids and brain atrophy in multiple sclerosis
Robert Zivadinov
BMC Medicine
|
December 19, 2013
Is there a link between the extracranial venous system and central nervous system pathology?
Robert Zivadinov
Neurology
|
July 20, 2007
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Robert Zivadinov
Methods and Findings in Experimental and Clinical Pharmacology
|
April 10, 2009
Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials
Robert Zivadinov
Neurology
|
November 2, 2011
Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?"
Robert Zivadinov, Karen Marr
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
May 18, 2010
Pathophysiology of demyelinating disorders
Alireza Minagar, Robert Zivadinov
Neurology
|
August 28, 2009
Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis?
Istvan Pirko, Robert Zivadinov
Radiology
|
June 25, 2020
Cervical Spinal Cord Lesions and Atrophy versus Brain Measures in Explaining Physical Disability in Multiple Sclerosis
Robert Zivadinov, Niels Bergsland
NMR in Biomedicine
|
September 25, 2018
Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping
Ferdinand Schweser, Robert Zivadinov
Page
of 50
Search research articles
Search
Showing results (1-10 of 495) with videos related to
Sort By:
Page
of 50
Radiology
|
May 23, 2018
Why Is Cognitive Impairment Present in Multiple Sclerosis? Insights from Functional MRI
Robert Zivadinov
Journal of the Neurological Sciences
|
May 11, 2005
Steroids and brain atrophy in multiple sclerosis
Robert Zivadinov
BMC Medicine
|
December 19, 2013
Is there a link between the extracranial venous system and central nervous system pathology?
Robert Zivadinov
Neurology
|
July 20, 2007
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Robert Zivadinov
Methods and Findings in Experimental and Clinical Pharmacology
|
April 10, 2009
Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials
Robert Zivadinov
Neurology
|
November 2, 2011
Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?"
Robert Zivadinov, Karen Marr
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
May 18, 2010
Pathophysiology of demyelinating disorders
Alireza Minagar, Robert Zivadinov
Neurology
|
August 28, 2009
Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis?
Istvan Pirko, Robert Zivadinov
Radiology
|
June 25, 2020
Cervical Spinal Cord Lesions and Atrophy versus Brain Measures in Explaining Physical Disability in Multiple Sclerosis
Robert Zivadinov, Niels Bergsland
NMR in Biomedicine
|
September 25, 2018
Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping
Ferdinand Schweser, Robert Zivadinov
Page
of 50